| Variables |
Frequency |
Percent |
| Gender |
|
|
| Male |
26 |
48.1 |
| Female |
28 |
51.9 |
| Types of tumor |
|
|
| AML |
9 |
16.7 |
| ALL |
11 |
20.4 |
| Ca.Breast |
2 |
3.7 |
| Burkitt's lymphoma |
2 |
3.7 |
| Colorectal carcinoma |
15 |
27.8 |
| HL |
3 |
5.6 |
| NHL |
2 |
3.7 |
| Wilm’stumour |
2 |
3.7 |
| Neuroblastoma |
1 |
1.9 |
| PNET |
1 |
1.9 |
| Osteosarcoma |
5 |
9.3 |
| Multiple Myeloma |
1 |
1.9 |
| Drug groups |
|
|
| Adriamycine, Bleomycin, DecarbazineVinblastin |
2 |
3.7 |
| Etoposide, Ifosfamide, Mesna |
5 |
9.3 |
| Daunorubicin, Cytosar |
6 |
11.1 |
| Methotrexate, Vincristion, Adriamycine |
2 |
3.7 |
| Daunorubicin, Methotrexate,Cychlophosphamide,
Cytosar |
4 |
7.4 |
| Methotrexate, Cytosar, L-asparginase |
1 |
1.9 |
| Daunorubicine, Etoposide, Ifosfamide, Decarbazine, |
4 |
7.4 |
| DoxorubicineCytosar, Vincristin, , L-asparginase |
3 |
5.6 |
| Adriamycine, Bleomycin, Decarbazine, Vincristin |
1 |
1.9 |
| Daunorubicin, Vincristin, L-asparginase, Pridinisolone |
1 |
1.9 |
| Methotrexate, Cychlophosphamide, 5-fluruouracil |
2 |
3.7 |
| 5-fluruouracil, Oxaloplatin, Avastin |
15 |
27.8 |
| Methotrexate, Vincristin, Cychlophosphamide, AdriamycineVinblastin, cisplatin, decarbazin, interferon |
7 |
13.0 |
| Total |
54 |
100% |
|